Seeking Alpha

Arena Pharmaceuticals (ARNA) +4.3% amid heavy trading and continuing the upward trend it's...

Arena Pharmaceuticals (ARNA) +4.3% amid heavy trading and continuing the upward trend it's enjoyed since April over excitement about its Belviq obesity treatment. SA author Efsinvestment says that with a Relative Strength Index of 65%, the stock needs a breather, although it will be worth buying after any pullback.
Comments (2)
  • Jason F
    , contributor
    Comments (217) | Send Message
     
    65 RSI needs a breather? I don't think so. That just indicates a strong trend, based on RSI the last few months...
    10 Jul 2012, 01:52 PM Reply Like
  • mikes454
    , contributor
    Comments (11) | Send Message
     
    Cramer needs to clarify all the inaccurate information he presented which has fueled the pull back.
    11 Jul 2012, 02:33 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs